ConductScience.org, home

Paper30765477

SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.

Nimmagadda SC and 7 others. Haematologica, 2019. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA. Papers, record 30765477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30765477

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.
PubMed
Journal
Haematologica
PubMed
Year
2019
PubMed
Publication types
Letter, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.12
iCite
Revised in PubMed
2026-01-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nimmagadda SCSubbaiah Chary
2Frey SStephanie
3Müller PPeter
4Wolleschak DDenise
5Weinert SSönke
6Keller UUlrich
7Edelmann BBärbel
8Fischer TThomas

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Agammaglobulinaemia Tyrosine KinaseMajor topic
Chemokine CXCL12Major topic
ChemotaxisMajor topic
Gene Expression RegulationMajor topic
Janus Kinase 2Major topic
MutationMajor topic
Myeloid Progenitor CellsMajor topic
Cell Movement
Cells, Cultured
Humans
Phosphatidylinositol 3-Kinases
Phospholipase C gamma
Proto-Oncogene Proteins c-akt
rhoA GTP-Binding Protein

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122160036Genetic and epigenetic complexity in myeloproliferative neoplasms.Hematology Am Soc Hematol Educ Program2011https://conductscience.org/library/papers/22160036PubMed
220843246Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.N Engl J Med2010https://conductscience.org/library/papers/20843246PubMed
328536953RhoA and RhoC are involved in stromal cell-derived factor-1-induced cell migration by regulating F-actin redistribution and assembly.Mol Cell Biochem2017https://conductscience.org/library/papers/28536953PubMed
49755164Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13.EMBO J1998https://conductscience.org/library/papers/9755164PubMed
521321325Rho GTPases and their role in organizing the actin cytoskeleton.J Cell Sci2011https://conductscience.org/library/papers/21321325PubMed
617239630Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.Immunity2007https://conductscience.org/library/papers/17239630PubMed
725394487Epo-induced erythroid maturation is dependent on Plcγ1 signaling.Cell Death Differ2015https://conductscience.org/library/papers/25394487PubMed
824307721Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia.Blood2014https://conductscience.org/library/papers/24307721PubMed
918292289Proteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-kappaB.Blood2008https://conductscience.org/library/papers/18292289PubMed
1025461253C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.Exp Hematol2015https://conductscience.org/library/papers/25461253PubMed
1129109446Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.Leukemia2018https://conductscience.org/library/papers/29109446PubMed
1228233092Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.J Cancer Res Clin Oncol2017https://conductscience.org/library/papers/28233092PubMed
1325565020Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myeloma.Cell Cycle2015https://conductscience.org/library/papers/25565020PubMed
1429121538Therapeutic options for leukemic transformation in patients with myeloproliferative neoplasms.Leuk Res2017https://conductscience.org/library/papers/29121538PubMed
1525294819Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML.Oncotarget2014https://conductscience.org/library/papers/25294819PubMed
1628903325CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner.Oncotarget2017https://conductscience.org/library/papers/28903325PubMed
1726538820Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation.Mediators Inflamm2015https://conductscience.org/library/papers/26538820PubMed
1828314843Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with JAK2 Mutation Status.Mol Cancer Res2017https://conductscience.org/library/papers/28314843PubMed
1930024857JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.J Clin Invest2018https://conductscience.org/library/papers/30024857PubMed
2027376361Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.Ann Hematol2016https://conductscience.org/library/papers/27376361PubMed

See all 21 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
35205715Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms.Cancers (Basel)2022https://conductscience.org/library/papers/35205715PubMed
34592754Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease.Blood Adv2021https://conductscience.org/library/papers/34592754PubMed
33641869Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.Hematol Oncol Clin North Am2021https://conductscience.org/library/papers/33641869PubMed
32112045Bone marrow niches in haematological malignancies.Nat Rev Cancer2020https://conductscience.org/library/papers/32112045PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
PLCG15335PubTator's text mininghttps://conductscience.org/library/genes/5335NCBI Gene
RHOA387PubTator's text mininghttps://conductscience.org/library/genes/387NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30765477

GET https://conductscience.org/api/papers/v1/30765477/references?page=2